Chronic tissue transplantation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy8

Aborted Fetus Ovary Transplants Antilymphocyte Serum Hematopoietic Stem Cells Liver T-Lymphocytes Bone Marrow Cells

Organisms3

Transplantation Chimera Rats, Inbred Lew Mice, Inbred C57BL

Diseases21

Primary Ovarian Insufficiency Graft vs Host Disease Liver Failure Postoperative Complications Recurrence Hematologic Neoplasms Cadaver Liver Diseases Kidney Failure, Chronic Leukemia Bronchiolitis Obliterans Anemia, Aplastic Blood Group Incompatibility Cytomegalovirus Infections Acute Disease End Stage Liver Disease Brain Death Liver Failure, Acute Multiple Myeloma Primary Graft Dysfunction Liver Cirrhosis

Chemicals and Drugs11

Immunosuppressive Agents Tacrolimus Cyclosporine Busulfan HLA Antigens Antilymphocyte Serum Mycophenolic Acid Myeloablative Agonists Cyclophosphamide Melphalan ABO Blood-Group System

Analytical, Diagnostic and Therapeutic Techniques and Equipment50

Tissue Transplantation Fetal Tissue Transplantation Brain Tissue Transplantation Organ Transplantation Liver Transplantation Hand Transplantation Transplantation, Heterotopic Transplantation, Homologous Transplantation Kidney Transplantation Bone Marrow Transplantation Skin Transplantation Hematopoietic Stem Cell Transplantation Cryopreservation Heart Transplantation Transplantation, Autologous Lung Transplantation Stem Cell Transplantation Transplantation Conditioning Pancreas Transplantation Islets of Langerhans Transplantation Cell Transplantation Transplantation, Isogeneic Treatment Outcome Cord Blood Stem Cell Transplantation Heart-Lung Transplantation Peripheral Blood Stem Cell Transplantation Retrospective Studies Immunosuppression Histocompatibility Testing Transplantation, Heterologous Mesenchymal Stem Cell Transplantation Corneal Transplantation Whole-Body Irradiation Follow-Up Studies Survival Analysis Survival Rate Facial Transplantation Donor Selection Organ Preservation Combined Modality Therapy Risk Factors Remission Induction Postoperative Period Tissue and Organ Harvesting Prognosis Neoplasm Transplantation Patient Selection Disease-Free Survival Prospective Studies

Phenomena and Processes8

Transplantation Immunology Graft Survival Graft Rejection Transplantation Tolerance Time Factors Histocompatibility Chimerism Cell Differentiation

Humanities5

Complicity Personhood Life Beginning of Human Life Ethics, Medical

Information Science1

Named Groups3

Tissue Donors Pregnant Women Living Donors

Health Care16

Directed Tissue Donation Tissue and Organ Procurement Hospitals, State Ethics, Medical Treatment Outcome Retrospective Studies Waiting Lists Follow-Up Studies Survival Analysis Survival Rate Donor Selection Risk Factors Postoperative Period Patient Selection Disease-Free Survival Prospective Studies

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Humanities Information Science Named Groups Health Care

Tissue Transplantation Complicity Fetal Tissue Transplantation Personhood Directed Tissue Donation Life Beginning of Human Life Brain Tissue Transplantation Aborted Fetus Tissue and Organ Procurement Hospitals, State Organ Transplantation Liver Transplantation Hand Transplantation Transplantation, Heterotopic Transplantation, Homologous Transplantation Tissue Donors Transplantation Immunology Kidney Transplantation Graft Survival Pregnant Women Bone Marrow Transplantation Primary Ovarian Insufficiency Ethics, Medical Skin Transplantation Hematopoietic Stem Cell Transplantation Cryopreservation Heart Transplantation Transplantation, Autologous Lung Transplantation Stem Cell Transplantation Transplantation Conditioning Ovary Graft Rejection Pancreas Transplantation Islets of Langerhans Transplantation Cell Transplantation Transplantation Chimera Immunosuppressive Agents Graft vs Host Disease Transplantation, Isogeneic Living Donors Treatment Outcome Cord Blood Stem Cell Transplantation Heart-Lung Transplantation Transplantation Tolerance Peripheral Blood Stem Cell Transplantation Liver Failure Retrospective Studies Immunosuppression Histocompatibility Testing Time Factors Postoperative Complications Waiting Lists Transplantation, Heterologous Recurrence Mesenchymal Stem Cell Transplantation Corneal Transplantation Histocompatibility Hematologic Neoplasms Tacrolimus Whole-Body Irradiation Cyclosporine Follow-Up Studies Cadaver Survival Analysis Survival Rate Facial Transplantation Donor Selection Liver Diseases Organ Preservation Busulfan Transplants HLA Antigens Kidney Failure, Chronic Leukemia Bronchiolitis Obliterans Combined Modality Therapy Risk Factors Antilymphocyte Serum Remission Induction Anemia, Aplastic Blood Group Incompatibility Cytomegalovirus Infections Mycophenolic Acid Postoperative Period Myeloablative Agonists Acute Disease Hematopoietic Stem Cells Tissue and Organ Harvesting Rats, Inbred Lew Mice, Inbred C57BL Cyclophosphamide Prognosis End Stage Liver Disease Liver Neoplasm Transplantation Patient Selection Disease-Free Survival

No FAQ available that match "chronic tissue transplantation"